tiprankstipranks
Omega Diagnostics Group PLC (GB:CNSL)
LSE:CNSL

Omega Diagnostics (CNSL) Share Price & Analysis

2 Followers

CNSL Stock Chart & Stats

Day’s Range0p - 0p
52-Week Range1.66p - 4.17p
Previous Close4p
Volume835.43K
Average Volume (3M)620.09K
Market Cap
£9.52M
Enterprise Value4.48M
Total Cash (Recent Filing)£5.12M
Total Debt (Recent Filing)£74.00K
Price to Earnings (P/E)-4.1
Beta0.85
Aug 05, 2024
>-£0.01
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding237,685,200
10 Day Avg. Volume5,746,398
30 Day Avg. Volume620,087
Standard Deviation0.84
R-Squared0.02
Alpha0.11
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)4845.07
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

6.56%0.00%0.00%93.44%
0.00% Other Institutional Investors
93.44% Public Companies and
Individual Investors

CNSL FAQ

What was Omega Diagnostics Group PLC’s price range in the past 12 months?
Omega Diagnostics Group PLC lowest share price was 1.66p and its highest was 4.17p in the past 12 months.
    What is Omega Diagnostics Group PLC’s market cap?
    Currently, no data Available
    When is Omega Diagnostics Group PLC’s upcoming earnings report date?
    Omega Diagnostics Group PLC’s upcoming earnings report date is Aug 05, 2024 which is in 77 days.
      How were Omega Diagnostics Group PLC’s earnings last quarter?
      Omega Diagnostics Group PLC released its earnings results on Nov 23, 2023. The company reported -0.003p earnings per share for the quarter, missing the consensus estimate of N/A by -0.003p.
        Is Omega Diagnostics Group PLC overvalued?
        According to Wall Street analysts Omega Diagnostics Group PLC’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Omega Diagnostics Group PLC pay dividends?
          Omega Diagnostics Group PLC does not currently pay dividends.
          What is Omega Diagnostics Group PLC’s EPS estimate?
          Omega Diagnostics Group PLC’s EPS estimate is >-£0.01.
            How many shares outstanding does Omega Diagnostics Group PLC have?
            Omega Diagnostics Group PLC has 237,950,650 shares outstanding.
              What happened to Omega Diagnostics Group PLC’s price movement after its last earnings report?
              Omega Diagnostics Group PLC reported an EPS of -0.003p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 7.843%.
                Which hedge fund is a major shareholder of Omega Diagnostics Group PLC?
                Currently, no hedge funds are holding shares in GB:CNSL
                ---

                Omega Diagnostics Stock Smart Score

                N/A
                Not Ranked
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Technicals

                SMA
                Positive
                20 days / 200 days
                Momentum
                60.00%
                12-Months-Change

                Fundamentals

                Return on Equity
                -30.47%
                Trailing 12-Months
                Asset Growth
                -19.68%
                Trailing 12-Months

                Company Description

                Omega Diagnostics Group PLC

                Omega Diagnostics Group PLC provides in-vitro diagnostics (IVD) products for use in hospitals, blood banks, clinics and laboratories and specializes in the areas of allergy and autoimmune, food intolerance and infectious diseases. It has three segments: The Allergy and autoimmune division specialise in the research, development, production, and marketing of in-vitro allergy and autoimmune tests used by doctors to diagnose patients with allergies and autoimmune diseases; The Food intolerance division specialises in the research, development, and production of kits to aid the detection of immune reactions to food; and The Infectious disease division specialises in the research, development, production, and marketing of kits to aid the diagnosis of infectious diseases.
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Tristel
                Futura Medical
                Synairgen
                Advanced Medical Solutions
                Popular Stocks
                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis